{
    "2021-01-05": [
        [
            {
                "time": "",
                "orginal_text": "齐鲁、信达等司生物类似药还能享多久“丰厚”定价？这家企业悄然发起价格战！集采会引爆战火吗？",
                "features": {
                    "keywords": [
                        "齐鲁",
                        "信达",
                        "生物类似药",
                        "定价",
                        "价格战",
                        "集采"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "9只个股尾盘净流入资金超亿元",
                "features": {
                    "keywords": [
                        "个股",
                        "尾盘",
                        "净流入",
                        "资金"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "27亿元定增方案获受理 博雅生物拟转投华润",
                "features": {
                    "keywords": [
                        "博雅生物",
                        "定增",
                        "华润",
                        "27亿元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11",
                "orginal_text": "医药行业2020年11月疫苗批签发数据跟踪报告：行业高景气，重点公司表现亮眼，维持“强于大市”评级",
                "features": {
                    "keywords": [
                        "医药行业",
                        "疫苗",
                        "批签发",
                        "高景气",
                        "重点公司",
                        "强于大市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}